Article

Development of Enterovirus anti-viral agents that target the viral 2C protein

medRxiv · 2022 · Kejriwal, R.; Evans, T.; Calabrese, J.; Swistak, L.; Alexandrescu, L.; Cohen, M.; Rahman, N.; Henriksen, N.; Dash, R. C.; Hadden, K.; Stonehouse, N. J.; Rowlands, D. J.; Kingston, N. J.; Hartnoll, M.; Dobson, S.; White, S.

Key facts

Title Development of Enterovirus anti-viral agents that target the viral 2C protein
First author Kejriwal, R.; Evans, T.; Calabrese, J.; Swistak, L.; Alexandrescu, L.; Cohen, M.; Rahman, N.; Henriksen, N.; Dash, R. C.; Hadden, K.; Stonehouse, N. J.; Rowlands, D. J.; Kingston, N. J.; Hartnoll, M.; Dobson, S.; White, S.
Journal medRxiv
Published Oct 14, 2022
DOI 10.1101/2022.10.06.511132
Devices mentioned BK110039, DEN000008, K022086, K202641, K231013
Product codes mentioned JCI, KIP, KIT, NDS, NJT, PFF, PFT, PCA, QBD

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature